Jefferies Group LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,003,167
+35.9%
150,100
+33.4%
0.03%
+11.5%
Q1 2021$2,945,250
+4.1%
112,5000.0%0.03%
+18.2%
Q4 2020$2,830,500
-40.9%
112,500
-35.4%
0.02%
-40.5%
Q3 2019$4,788,000
+2.7%
174,223
+23.7%
0.04%
+8.8%
Q2 2019$4,662,000
+179.3%
140,893
+195.7%
0.03%
+142.9%
Q1 2019$1,669,000
+5.8%
47,641
+52.0%
0.01%
+40.0%
Q3 2018$1,578,000
+447.9%
31,340
+552.2%
0.01%
+400.0%
Q2 2018$288,000
-25.2%
4,805
-50.2%
0.00%0.0%
Q4 2017$385,000
-84.5%
9,652
-83.2%
0.00%
-87.5%
Q2 2017$2,479,000
+12.7%
57,500
-18.2%
0.02%0.0%
Q1 2017$2,200,000
+73233.3%
70,271
+43277.2%
0.02%
Q2 2015$3,000
-99.4%
162
-99.6%
0.00%
-100.0%
Q1 2015$544,000
-87.7%
44,990
-91.2%
0.00%
-90.0%
Q3 2014$4,419,000
+61.1%
508,536
+103.0%
0.03%
+30.4%
Q2 2014$2,743,000
+2439.8%
250,472
+1603.9%
0.02%
+2200.0%
Q3 2013$108,00014,7000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders